At Phacilitate Leaders Europe 2019 (London, UK), Pilar Pinilla Domínguez, a senior scientific adviser from the UK’s regulatory agency NICE (London, UK), discusses regulating advanced therapies.
Pilar Pinilla-Domínguez, a senior advisor from NICE (London, UK), the UK’s healthcare regulator, talked to RegMedNet during Phacilitate Leaders Europe 2019 (London, UK). As a guest speaker at the conference, she spoke on the ‘reimbursement models for advanced therapies’, a session co-organized by MedCity (London, UK).
In our latest interview, you can listen to her discuss how NICE approach regulating advanced therapeutic medical products (ATMPs) in the UK, the impact of CAR-T therapy has had on the field and also the importance of hearing the patients’ voice when designing and considering therapies.
Have any additional questions about this story? Ask us in the comments, below.
Find out more in these top picks from the Editor:
- The evolution of automation in bioprocessing: an interview with Ioannis Papantoniou
- Understanding and innovating in cell therapy quality control: an interview with Stephen Sullivan, GAiT
- Developing and commercializing peptide therapeutics for nerve regeneration: an interview with NervGen Pharma